Locally Advanced Pancreatic Adenocarcinoma

Oncology
3
Pipeline Programs
5
Companies
4
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

EXACT Therapeutics
EXACT TherapeuticsNorway - Oslo
1 program
1
Acoustic Cluster TherapyPhase 21 trial
Active Trials
NCT06850623Recruiting25Est. Jul 2027
Biotest Pharmaceuticals
Biotest PharmaceuticalsGermany - Dreieich
1 program
1
NanoPac®Phase 21 trial
Active Trials
NCT03077685CompletedEst. Mar 2023
Providence Therapeutics
1 program
1
tadalafil and vaccinationPhase 11 trial
Active Trials
NCT01342224CompletedEst. Apr 2018
OncoSil Medical
OncoSil MedicalAustralia - Macquarie Park
1 program
OncoSilN/A1 trial
Active Trials
NCT06399172Not Yet RecruitingEst. Oct 2029

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
EXACT TherapeuticsAcoustic Cluster Therapy
Biotest PharmaceuticalsNanoPac®
Providence Therapeuticstadalafil and vaccination
OncoSil MedicalOncoSil

Clinical Trials (4)

Total enrollment: 25 patients across 4 trials

NCT06850623EXACT TherapeuticsAcoustic Cluster Therapy

Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer

Start: Jun 2025Est. completion: Jul 202725 patients
Phase 2Recruiting

Trial of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma

Start: Dec 2017Est. completion: Mar 2023
Phase 2Completed
NCT01342224Providence Therapeuticstadalafil and vaccination

Immunochemoradiotherapy in Patients With Pancreatic Cancer

Start: Jan 2011Est. completion: Apr 2018
Phase 1Completed

OncoSil Pancreatic Cancer Post-marketing Clinical Registry - Italy

Start: May 2024Est. completion: Oct 2029
N/ANot Yet Recruiting

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 25 patients
5 companies competing in this space